forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Agonists Weight Loss Drugs Market Size, Share & Trends Analysis by Drugs (Semaglutide (Wegovy), (Zepbound)), Route of Administration, Distribution Channel, and Region with Forecasts, -2030 GLP-1 Receptor Agonist Market Size

doi: 10.1038/s41598-025-01206-9 162 BrierleyDIHoltMKSinghADe AraujoAMcDougleMVergaraMet al

Keep documentation (prescription label, doctors note if available) readily available to ensure a smooth and quick process

Geneva, Switzerland: World Health Organization

If youre currently taking Saxenda and your supply has been affected, speak with your prescriber about switching to Nevolat, or about whether Wegovy might be a more effective alternative

This helps identify whether specific side effects are medication-specific or transition-specific

Individuals taking lower doses of semaglutide also experience significant weight loss